Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome
- 1 June 2000
- journal article
- clinical trial
- Published by Elsevier
- Vol. 73 (6) , 1149-1154
- https://doi.org/10.1016/s0015-0282(00)00501-x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effects of Metformin on Spontaneous and Clomiphene-Induced Ovulation in the Polycystic Ovary SyndromeNew England Journal of Medicine, 1998
- Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndromeFertility and Sterility, 1998
- Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes MellitusNew England Journal of Medicine, 1998
- Menstrual Cyclicity After Metformin Therapy in Polycystic Ovary SyndromeObstetrics & Gynecology, 1997
- Adrenal Involvement in Polycystic Ovary SyndromeSeminars in Reproductive Medicine, 1997
- Metabolic Effects of Metformin in Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1995
- Polycystic ovary syndromeCurrent Opinion in Obstetrics and Gynecology, 1994
- Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancyMetabolism, 1994
- Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.Journal of Clinical Investigation, 1989
- Variation in facial and pubic hair growth in white womenAmerican Journal of Physical Anthropology, 1957